GB0808710D0 - New combination 296 - Google Patents

New combination 296

Info

Publication number
GB0808710D0
GB0808710D0 GB0808710A GB0808710A GB0808710D0 GB 0808710 D0 GB0808710 D0 GB 0808710D0 GB 0808710 A GB0808710 A GB 0808710A GB 0808710 A GB0808710 A GB 0808710A GB 0808710 D0 GB0808710 D0 GB 0808710D0
Authority
GB
United Kingdom
Prior art keywords
new combination
new
combination
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0808710A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Argenta Discovery Ltd
AstraZeneca AB
Original Assignee
Argenta Discovery Ltd
AstraZeneca AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Argenta Discovery Ltd, AstraZeneca AB filed Critical Argenta Discovery Ltd
Priority to GB0808710A priority Critical patent/GB0808710D0/en
Publication of GB0808710D0 publication Critical patent/GB0808710D0/en
Priority to CA2723909A priority patent/CA2723909A1/en
Priority to BRPI0912657A priority patent/BRPI0912657A2/en
Priority to CN2012104520326A priority patent/CN102908624A/en
Priority to MX2010012019A priority patent/MX2010012019A/en
Priority to RU2010147881/15A priority patent/RU2010147881A/en
Priority to EP09746868.0A priority patent/EP2315589A4/en
Priority to KR1020107025392A priority patent/KR20110010725A/en
Priority to JP2011509442A priority patent/JP2011520877A/en
Priority to US12/992,226 priority patent/US20110190309A1/en
Priority to CN200980127403XA priority patent/CN102088976B/en
Priority to PCT/SE2009/050525 priority patent/WO2009139708A1/en
Priority to AU2009247021A priority patent/AU2009247021B2/en
Ceased legal-status Critical Current

Links

GB0808710A 2008-05-13 2008-05-13 New combination 296 Ceased GB0808710D0 (en)

Priority Applications (13)

Application Number Priority Date Filing Date Title
GB0808710A GB0808710D0 (en) 2008-05-13 2008-05-13 New combination 296
AU2009247021A AU2009247021B2 (en) 2008-05-13 2009-05-12 Pharmaceutical product comprising a muscarinic receptor antagonist and a beta2-adrenoceptor agonist
EP09746868.0A EP2315589A4 (en) 2008-05-13 2009-05-12 PHARMACEUTICAL PRODUCT COMPRISING A MUSCARINIC RECEPTOR ANTAGONIST AND A beta2-ADRENOCEPTOR AGONIST
BRPI0912657A BRPI0912657A2 (en) 2008-05-13 2009-05-12 pharmaceutical product comprising a muscarinic receptor antagonist and a beta2-adrenoreceptor agonist
CN2012104520326A CN102908624A (en) 2008-05-13 2009-05-12 Pharmaceutical product comprising a muscarinic receptor antagonist and a beta2-adrenoceptor agonist
MX2010012019A MX2010012019A (en) 2008-05-13 2009-05-12 Pharmaceutical product comprising a muscarinic receptor antagonist and a î²2-adrenoceptor agonist.
RU2010147881/15A RU2010147881A (en) 2008-05-13 2009-05-12 PHARMACEUTICAL PRODUCT CONTAINING A MUSCARIN RECEPTOR ANTAGONIST AND β2-ADRENOREPTECT AGONIST
CA2723909A CA2723909A1 (en) 2008-05-13 2009-05-12 Pharmaceutical product comprising a muscarinic receptor antagonist and a beta2-adrenoceptor agonist
KR1020107025392A KR20110010725A (en) 2008-05-13 2009-05-12 PHARMACEUTICAL PRODUCT COMPRISING A MUSCARINIC RECEPTOR ANTAGONIST AND A β2-ADRENOCEPTOR AGONIST
JP2011509442A JP2011520877A (en) 2008-05-13 2009-05-12 Medicament containing muscarinic receptor antagonist and β2-adrenergic receptor agonist
US12/992,226 US20110190309A1 (en) 2008-05-13 2009-05-12 PHARMACEUTICAL PRODUCT COMPRISING A MUSCARINIC RECEPTOR ANTAGONIST AND A Beta2-ADRENOCEPTOR AGONIST
CN200980127403XA CN102088976B (en) 2008-05-13 2009-05-12 Pharmaceutical product comprising a muscarinic receptor antagonist and a beta2-adrenoceptor agonist
PCT/SE2009/050525 WO2009139708A1 (en) 2008-05-13 2009-05-12 PHARMACEUTICAL PRODUCT COMPRISING A MUSCARINIC RECEPTOR ANTAGONIST AND A β2-ADRENOCEPTOR AGONIST

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0808710A GB0808710D0 (en) 2008-05-13 2008-05-13 New combination 296

Publications (1)

Publication Number Publication Date
GB0808710D0 true GB0808710D0 (en) 2008-06-18

Family

ID=39571296

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0808710A Ceased GB0808710D0 (en) 2008-05-13 2008-05-13 New combination 296

Country Status (1)

Country Link
GB (1) GB0808710D0 (en)

Similar Documents

Publication Publication Date Title
IL208405A0 (en) Substituted pyrimidin-5-carboxamides 281
GB0811099D0 (en) New combination 376
GB0808709D0 (en) New combination 295
GB0905087D0 (en) Cypardon 2
GB0808710D0 (en) New combination 296
GB0808845D0 (en) 10000003
GB0808958D0 (en) 10000004
GB0809700D0 (en) Florierre 2400
GB0810603D0 (en) Corcost prepost 001
GB0813671D0 (en) Corcost prepost 2020
GB0818445D0 (en) Cocept 46
GB0808847D0 (en) 10000001
GB0808846D0 (en) 10000002
GB0807658D0 (en) Sebaforce 2
GB0808042D0 (en) Advance 002
GB0808551D0 (en) Note 200002
GB0808544D0 (en) Note 200010
GB0808545D0 (en) Note 200009
GB0808546D0 (en) Note 200008
GB0808547D0 (en) Note 200007
GB0808548D0 (en) Note 200005
GB0808549D0 (en) Note 200004
GB0808550D0 (en) Note 200003
GB0805897D0 (en) Note 10001
GB0808552D0 (en) Note 200006

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)